Rapid Novor Email Format

Biotechnology ResearchOntario, Canada51-200 Employees

Rapid Novor is a mid-sized biotechnology firm based in Kitchener, Ontario, focusing on antibody protein sequencing through mass spectrometry. It originated as a University of Waterloo spin-off, drawing on decades of research led by co-founder and chief scientist Dr. Bin Ma. The company enables direct sequencing of antibody proteins without requiring access to the producing cell line, supporting robust characterization of antibody therapeutics.

Its customers include researchers in pharma, biotech, and academia who develop, characterize, and monitor antibody-based therapies. Through its sequencing services, Rapid Novor aims to streamline validation and enable insights across antibody workflows, including discovery and clinical research contexts. A notable recent development is the May 2024 announcement that the company enrolled the first patient in a clinical study evaluating EasyM for disease response analysis in newly diagnosed multiple myeloma, illustrating the clinical applicability of its technology.

Sign up for free to view info

Company overview Employee directory